Published August 5, 2026
| Version v1
Dataset
Open
Dataset: Hypothesis: Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging - PathMap Experiment #000100
Description
Interactive Data Viewer: Read, View, and Print from Day 1
Use our fully interactive viewer to view, read, and print this research data right from Day 1:
https://pathmap.org/viewer.php?id=100
Artificial General Intelligence LLC
Claim Evaluated: Hypothesis: Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging
This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine.
🔍 Novel & Overlooked Insights
- Erythroblasts in the bone marrow act as a key regulatory niche by generating specialized pro-resolving mediators (SPMs) that instruct neutrophil development and prevent premature senescent-like functional shifts.
- The accumulation of senescent cells, such as vascular smooth muscle cells (VSMCs), generates a senescence-associated secretory phenotype (SASP) that creates a "don't-eat-me" environment, directly disrupting macrophage efferocytosis in atherosclerosis.
- The "charge-sensitive" recognition mechanism, modulated by pH and cationic molecules, reveals that the microenvironment itself acts as a regulatory checkpoint for neutrophil clearance, independent of classical receptor-ligand interactions.
- NETs (Neutrophil Extracellular Traps) not only promote inflammation but also actively inhibit efferocytosis by cleaving macrophage surface integrins like αvβ3 and αvβ5, creating a feedback loop of persistent cellular debris.
- The metabolic state of the macrophage, particularly mitochondrial health and ROS-sensing pathways (e.g., DRP1 sulfenylation, AMPK phosphorylation), is an intrinsic requirement for the successful resolution of neutrophil-driven injury.
- Commensal-derived metabolites, such as indole-3-acetaldehyde, provide a microbiome-host axis that enhances macrophage phagocytosis via PXR/NRF2 signaling, suggesting that the lung microbiome is a modulator of efferocytic efficiency.
- The failure of "resolution programs" in disease is more significant than the failure of "anti-inflammatory" pathways, as evidenced by the failure of traditional anti-inflammatory drugs in clinical settings.
- Small-molecule TKIs, like neratinib, possess previously unrecognized pro-resolving properties, offering a repurposing opportunity to restore MerTK-mediated efferocytosis in multimorbid patients.
- The transition from monocyte to tissue-resident macrophage requires the enzyme deoxyhypusine synthase (DHPS).
- Cardiac resident macrophages rely on Maresin 1 (MaR1) signaling, which binds to PPARγ to induce CD204 expression, an efferocytosis-related target.
- The pentose phosphate pathway (PPP) is preferentially activated in resident thymic macrophages to manage the reduction-oxidation stress associated with efferocytosis.
- Systemic iron homeostasis and complement regulation, influenced by Tregs in the brain, also utilize efferocytosis-related receptors like MERTK and AXL.
- Microbiome modulation, including probiotics like *L. plantarum* and *L. reuteri*, can alter tryptophan metabolism (e.g., indole derivatives) to promote an anti-inflammatory state.
- The "interferon gap" in the elderly can be mitigated by mucosal Th1-Trm activation, proving that the mucosal immune reservoir is highly dynamic.
- Nano-bio interfaces, such as PET nanoplastic protein coronas, can pathologically rewire macrophage efferocytosis to facilitate tumor immune evasion.
🧪 Extracted Custom Datapoints
📊 Suggested Experiments
- Assess if pharmacological targeting of the charge-sensitive recognition mechanism (using cationic modulators) enhances neutrophil clearance in an aged mouse model.
- Determine if systemic administration of resolvin D5 (n-3 DPA) derived from erythroblasts can rejuvenate the peripheral macrophage efferocytic phenotype in aged organisms.
- Evaluate if inhibiting NETs using DNase I in aged models restores the CD36/MerTK signaling axis in tissue-resident macrophages.
- Assess if aerosolized IAAld treatment in aged mice reduces serum markers of systemic inflammation.
- Evaluate the impact of FMT from young to aged mice on alveolar macrophage efferocytic gene expression profiles.
- Measure systemic insulin sensitivity following targeted pulmonary AM efferocytosis restoration in diabetic murine models.
📊 Suggested Studies
- Longitudinal analysis of human patient cohorts to correlate systemic efferocytosis efficiency with biological markers of aging (e.g., epigenetic clocks).
- Cross-species study on the evolution of efferocytosis efficiency relative to longevity across long-lived and short-lived mammals.
- Investigation of the gut-lung axis in regulating efferocytosis via microbial metabolites in age-related respiratory declines.
- Longitudinal cohort analysis of respiratory commensal metabolites in healthy vs. accelerated aging populations.
- Spatial transcriptomics investigation of pulmonary macrophages in age-related frailty, focused on efferocytic receptor density.
- Meta-analysis of microbiome-targeted therapies and their impact on systemic inflammatory biomarkers (CRP/IL-6) in patients.
📊 Swansons Literature Based Discovery Candidates
- Enhancement of erythroblast-derived Resolvin D5 (RvD5n-3 DPA) signaling may ameliorate age-associated cognitive decline by normalizing the microglia-driven efferocytic resolution program.
- Erythroblast-derived Resolvin D5 (RvD5n-3 DPA) imprints neutrophil development and function (ID: 42519831).
- Reducing TRM EP2 signaling (which coordinates TRM function) limits cognitive decline in aged mice (ID: 42462036).
- Microglia/Brain-resident macrophages as the common cell type (specialized tissue-resident macrophages).
- Since erythroblasts imprint systemic granulopoiesis and tissue-resident macrophage status, and tissue-resident macrophages in the brain coordinate cognitive decline, increasing local pro-resolving lipid mediator signaling (like RvD5) may modulate the resident immune cell niche in the brain, thereby mimicking the cognitive-sparing effects of EP2 signaling inhibition.
- Indole-3-acetaldehyde (IAAld) acts as a potential therapeutic agent for age-related cardiac remodeling by modulating the cardiac resident macrophage (CRM) efferocytosis axis.
- IAAld as a metabolite of R. mucilaginosa enhances AM phagocytosis via PXR/NRF2 (ID 41715099).
- CRM efferocytosis promotes myocardial I/R resolution and reduces fibrosis (ID 41554295).
- PPAR-γ and NRF2 pathway integration in macrophage metabolism and inflammatory resolution.
- Both NRF2 and PPAR-γ converge on metabolic reprogramming of macrophages to improve efferocytic efficiency; IAAld-mediated activation of the PXR/NRF2 axis in AMs may be applicable to CRMs to mitigate age-related myocardial fibrosis.
📊 Contradictions Between Evidences
- While most evidence points to increased inflammation and impaired efferocytosis in aging, ID: 18467696 notes that adult mice show an early and acute 'cytokine storm' that is more lethal than in young mice, while ID: 18387441 reports suppressed inflammation and delayed granulation tissue in senescent hearts following injury. This suggests a context-dependent resolution dysfunction rather than simple 'inflamm-aging'.
- None identified in the current set; all sources consistently link macrophage efferocytic dysfunction to pathology.
📊 Repurposed Solutions
- Neratinib (an ErbB tyrosine kinase inhibitor) can be repurposed as an immunoresolvent to restore MerTK expression and efferocytosis in chronic inflammatory diseases (ID: 41857730). Additionally, Fucoidan can be utilized to activate the Gas6/MerTK pathway to reduce neuroinflammation (ID: 41351868).
- Probiotics/postbiotics designed for gut-lung axis modulation (like L. lactis or Mn-CDs) could be repurposed for cardiac or hepatic repair by leveraging common efferocytic pathways.
📊 Lung Microbiome Axis
- IAAld enhances RAMs/AMs phagocytosis, effectively clearing apoptotic neutrophils and LPS, which is crucial in aged tissues where efferocytic gene signatures are downregulated.
📊 Systemic Crosstalk
- Restoration of TRM efferocytosis prevents the release of paracrine stress signals from the lung/liver, thereby dampening systemic inflammation and distal tissue damage in aged subjects.
📊 Metabolic Checkpoint
- Yes, IAAld-mediated NRF2 nuclear translocation upregulates CD36, providing a metabolic checkpoint to restore phagocytic potential and mitochondrial fitness lost during aging.
Tags Attractor Table
| Extracted Keywords & Entities |
|---|
| Aging, _gates_from_aging, Phagocytosis, _gates_to_phagocytosis, _gates_from_phagocytosis, Neutrophils, _gates_to_neutrophils, _gates_from_neutrophils, _gates_to_aging, Indoleacetic Acids, _gates_from_indoleacetic_acids, Pregnane X Receptor, _gates_to_pregnane_x_receptor, NF-E2-Related Factor 2, _gates_from_nf-e2-related_factor_2, Macrophages, Alveolar, _gates_to_macrophages,_alveolar, _gates_from_macrophages,_alveolar, Inflammation, _gates_to_inflammation |
Run Your Own Analysis
PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.
Notes
Files
100.zip
Additional details
Related works
- Is documented by
- https://pathmap.org/viewer.php?id=100 (URL)